Author

Saba Tahir

Observed name: S. Tahir

Institution: University of Wah

Observed institutions: University of Wah, Leicester Royal Infirmary, Broomfield Hospital

ORCID: 0000-0001-9892-2270

Observed ORCID: 0000-0001-9892-2270

OpenAlex ID: A5012269259

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

2018 · P.G. Corrie, P.G. Corrie, et al. · Annals of Oncology · 68

Hybrid ionogel membrane of PVDF incorporating ionic liquid-reduced graphene oxide for the removal of heavy metal ions from synthetic water

2023 · Humaira Razzaq, Amna Siddique, et al. · Materials Science and Engineering B · 20

Integrated synergy: PSF/PANI/GO membranes for dual-action textile dye detoxification

2024 · Anila Tabasum, Amna Siddique, et al. · Materials Advances · 19

Early renal damage assessed by the SLICC/ACR damage index is predictor of severe outcome in lupus patients in Pakistan

2010 · MA Rabbani, HB Habib, et al. · Lupus · 17

A Comprehensive Review on Functionalized Graphene Oxide Nanoparticles for Fluorescence Properties and Potential in Biosensing and Water Remediation

2025 · Saba Tahir, Fawad Ahmad, et al. · ChemistrySelect · 8

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

2019 · P.G. Corrie, A. Marshall, et al. · Annals of Oncology · 8

Low dose sequential docetaxel-capecitabine chemotherapy as first-line treatment of metastatic breast cancer (mbc)

2008 · M. Hafeez, A. Shaharyar, et al. · Journal of Clinical Oncology

Gemcitabine-cisplatin-anastrozole concomitant chemo-hormonal treatment in locally advanced breast cancer in postmenopausal women

2008 · Z. Nadeem, A. Shaharyar, et al. · Journal of Clinical Oncology

Works count: 8

Citation count: 140

H-index: 6

I10-index: 4